The Use of Autologous Protein Solution (Pro-Stride®) and Leukocyte-Rich Platelet-Rich Plasma (Restigen®) in Canine Medicine

The Use of Autologous Protein Solution (Pro-Stride®) and Leukocyte-Rich Platelet-Rich Plasma (Restigen®) in Canine Medicine

William King,1 Kevin Cawood,2 Megan Bookmiller2 1Owl Manor, Warsaw, IN, USA; 2Indian Creek Veterinary Hospital, Fort Wayne, IN, USACorrespondence: William KingOwl Manor, 720 E Winona Ave, Warsaw, IN, 46580, USATel +1 574 267 4391Fax +1 866 602 5275Email william.king@owlmanormedical.comAbstract: The...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: King W, Cawood K, Bookmiller M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
aps
prp
canine
anti-inflammatory
orthopedics
osteoarthritis
Veterinary medicine
SF600-1100
Acceso en línea:https://doaj.org/article/9581b94fb31a4560829aaab418ebb287
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9581b94fb31a4560829aaab418ebb287
record_format dspace
spelling oai:doaj.org-article:9581b94fb31a4560829aaab418ebb2872021-12-02T13:17:45ZThe Use of Autologous Protein Solution (Pro-Stride®) and Leukocyte-Rich Platelet-Rich Plasma (Restigen®) in Canine Medicine2230-2034https://doaj.org/article/9581b94fb31a4560829aaab418ebb2872021-03-01T00:00:00Zhttps://www.dovepress.com/the-use-of-autologous-protein-solution-pro-stridereg-and-leukocyte-ric-peer-reviewed-article-VMRRhttps://doaj.org/toc/2230-2034William King,1 Kevin Cawood,2 Megan Bookmiller2 1Owl Manor, Warsaw, IN, USA; 2Indian Creek Veterinary Hospital, Fort Wayne, IN, USACorrespondence: William KingOwl Manor, 720 E Winona Ave, Warsaw, IN, 46580, USATel +1 574 267 4391Fax +1 866 602 5275Email william.king@owlmanormedical.comAbstract: The use of autologous orthobiologics is an emerging area of interest in veterinary medicine. In this retrospective study, we reviewed the clinical results achieved using two orthobiologics devices to address orthopedic injuries and tissue repair. Leukocyte (White blood cell)-rich platelet-rich plasma (L-PRP) devices produce outputs containing high concentrations of growth factors from venous blood. The Autologous Protein Solution (APS) device produces an orthobiologic containing high concentrations of growth factors and anti-inflammatory cytokines. L-PRP has commonly been used to address soft tissue injuries. APS has been injected into the joint to address osteoarthritis. In the last five years, our practice has treated 35 dogs (38 treatments) with L-PRP and 98 dogs (108 treatments) with APS. Our group has used L-PRP and APS to address orthopedic conditions including osteoarthritis, bursitis, tendinitis, tendon/ligament rupture/repair procedures, post-surgical femoral head osteotomy/tibial-plateau-leveling osteotomy tissue repair, lumbosacral stenosis, patellar luxation, joint laxity, and osteochondral dissecans. The results achieved with L-PRP and APS have been favorable (observed pain improvement and minimal adverse reactions), but sometimes have not achieved complete pain relief or tissue repair. The most common application for L-PRP was patellar luxation and the most common application for APS was injection post-ACL surgery. Canine OA has been successfully managed in several patients with repeat injections of APS over the course of several years. Future studies on specific conditions are ongoing and including efforts to further characterize these products in canine medicine.Keywords: APS, PRP, canine, anti-inflammatory, orthopedics, osteoarthritisKing WCawood KBookmiller MDove Medical Pressarticleapsprpcanineanti-inflammatoryorthopedicsosteoarthritisVeterinary medicineSF600-1100ENVeterinary Medicine: Research and Reports, Vol Volume 12, Pp 53-65 (2021)
institution DOAJ
collection DOAJ
language EN
topic aps
prp
canine
anti-inflammatory
orthopedics
osteoarthritis
Veterinary medicine
SF600-1100
spellingShingle aps
prp
canine
anti-inflammatory
orthopedics
osteoarthritis
Veterinary medicine
SF600-1100
King W
Cawood K
Bookmiller M
The Use of Autologous Protein Solution (Pro-Stride®) and Leukocyte-Rich Platelet-Rich Plasma (Restigen®) in Canine Medicine
description William King,1 Kevin Cawood,2 Megan Bookmiller2 1Owl Manor, Warsaw, IN, USA; 2Indian Creek Veterinary Hospital, Fort Wayne, IN, USACorrespondence: William KingOwl Manor, 720 E Winona Ave, Warsaw, IN, 46580, USATel +1 574 267 4391Fax +1 866 602 5275Email william.king@owlmanormedical.comAbstract: The use of autologous orthobiologics is an emerging area of interest in veterinary medicine. In this retrospective study, we reviewed the clinical results achieved using two orthobiologics devices to address orthopedic injuries and tissue repair. Leukocyte (White blood cell)-rich platelet-rich plasma (L-PRP) devices produce outputs containing high concentrations of growth factors from venous blood. The Autologous Protein Solution (APS) device produces an orthobiologic containing high concentrations of growth factors and anti-inflammatory cytokines. L-PRP has commonly been used to address soft tissue injuries. APS has been injected into the joint to address osteoarthritis. In the last five years, our practice has treated 35 dogs (38 treatments) with L-PRP and 98 dogs (108 treatments) with APS. Our group has used L-PRP and APS to address orthopedic conditions including osteoarthritis, bursitis, tendinitis, tendon/ligament rupture/repair procedures, post-surgical femoral head osteotomy/tibial-plateau-leveling osteotomy tissue repair, lumbosacral stenosis, patellar luxation, joint laxity, and osteochondral dissecans. The results achieved with L-PRP and APS have been favorable (observed pain improvement and minimal adverse reactions), but sometimes have not achieved complete pain relief or tissue repair. The most common application for L-PRP was patellar luxation and the most common application for APS was injection post-ACL surgery. Canine OA has been successfully managed in several patients with repeat injections of APS over the course of several years. Future studies on specific conditions are ongoing and including efforts to further characterize these products in canine medicine.Keywords: APS, PRP, canine, anti-inflammatory, orthopedics, osteoarthritis
format article
author King W
Cawood K
Bookmiller M
author_facet King W
Cawood K
Bookmiller M
author_sort King W
title The Use of Autologous Protein Solution (Pro-Stride®) and Leukocyte-Rich Platelet-Rich Plasma (Restigen®) in Canine Medicine
title_short The Use of Autologous Protein Solution (Pro-Stride®) and Leukocyte-Rich Platelet-Rich Plasma (Restigen®) in Canine Medicine
title_full The Use of Autologous Protein Solution (Pro-Stride®) and Leukocyte-Rich Platelet-Rich Plasma (Restigen®) in Canine Medicine
title_fullStr The Use of Autologous Protein Solution (Pro-Stride®) and Leukocyte-Rich Platelet-Rich Plasma (Restigen®) in Canine Medicine
title_full_unstemmed The Use of Autologous Protein Solution (Pro-Stride®) and Leukocyte-Rich Platelet-Rich Plasma (Restigen®) in Canine Medicine
title_sort use of autologous protein solution (pro-stride®) and leukocyte-rich platelet-rich plasma (restigen®) in canine medicine
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/9581b94fb31a4560829aaab418ebb287
work_keys_str_mv AT kingw theuseofautologousproteinsolutionprostrideregandleukocyterichplateletrichplasmarestigenregincaninemedicine
AT cawoodk theuseofautologousproteinsolutionprostrideregandleukocyterichplateletrichplasmarestigenregincaninemedicine
AT bookmillerm theuseofautologousproteinsolutionprostrideregandleukocyterichplateletrichplasmarestigenregincaninemedicine
AT kingw useofautologousproteinsolutionprostrideregandleukocyterichplateletrichplasmarestigenregincaninemedicine
AT cawoodk useofautologousproteinsolutionprostrideregandleukocyterichplateletrichplasmarestigenregincaninemedicine
AT bookmillerm useofautologousproteinsolutionprostrideregandleukocyterichplateletrichplasmarestigenregincaninemedicine
_version_ 1718393344751566848

Ejemplares similares